Yang; Seok-Woo Patent Filings

Patent	Date
Pharmaceutical Composition Containing, As Active Ingredient, Fusion Protein In Which Tumor-penetrating Peptide And Antiangiogenesis Agent Are Fused, For Preventing And Treating Cancer Or Angiogenesis-related Diseases App 20210253657 - Kwon; Hyuk-Sang ; et al.	2021-08-19
Pharmaceutical Composition For Preventing And Treating Eye Diseases, Containing, As Active Ingredient, Fusion Protein In Which Tissue-penetrating Peptide And Anti-vascular Endothelial Growth Factor Preparation Are Fused App 20210220436 - KIM; Seong Beom ; et al.	2021-07-22
Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factor Grant 11,052,130 - Kim , et al. July 6, 2	2021-07-06
Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases Grant 10,919,947 - Kwon , et al. February 16, 2	2021-02-16
Pharmaceutical Composition Containing, As Active Ingredient, Fusion Protein In Which Tumor-penetrating Peptide And Anti-angiogenesis Agent Are Fused, For Preventing And Treating Cancer Or Angiogenesis-related Diseases App 20180237484 - Kwon; Hyuk-Sang ; et al.	2018-08-23
Pharmaceutical Composition For Preventing And Treating Eye Diseases, Containing, As Active Ingredient, Fusion Protein In Which Tissue-penetrating Peptide And Anti-vascular Endothelial Growth Factor Preparation Are Fused App 20180133288 - KIM; Seong Beom ; et al.	2018-05-17

Patent

Date

Pharmaceutical Composition Containing, As Active Ingredient, Fusion Protein In Which Tumor-penetrating Peptide And Antiangiogenesis Agent Are Fused, For Preventing And Treating Cancer Or Angiogenesis-related Diseases
App 20210253657 - Kwon; Hyuk-Sang ; et al.

2021-08-19

Pharmaceutical Composition For Preventing And Treating Eye Diseases, Containing, As Active Ingredient, Fusion Protein In Which Tissue-penetrating Peptide And Anti-vascular Endothelial Growth Factor Preparation Are Fused
App 20210220436 - KIM; Seong Beom ; et al.

2021-07-22

Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factor
Grant 11,052,130 - Kim , et al. July 6, 2

2021-07-06

Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases
Grant 10,919,947 - Kwon , et al. February 16, 2

2021-02-16

Pharmaceutical Composition Containing, As Active Ingredient, Fusion Protein In Which Tumor-penetrating Peptide And Anti-angiogenesis Agent Are Fused, For Preventing And Treating Cancer Or Angiogenesis-related Diseases
App 20180237484 - Kwon; Hyuk-Sang ; et al.

2018-08-23

2018-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Yang; Seok-Woo

Patent Applications and Registrations